Biological and conformational studies on analogues of a synthetic peptide enhancing HIV-1 infection

This publication has 18 references indexed in Scilit:

• HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor
  Science, 1996
• SPC3, a synthetic peptide derived from the V3 domain of human immunodeficiency virus type 1 (HIV-1) gp120, inhibits HIV-1 entry into CD4+ and CD4- cells by two distinct mechanisms.
  Proceedings of the National Academy of Sciences, 1995
• Minimal Sequence Requirements for Synthetic Peptides Derived from the V3 Loop of the Human Immunodeficiency Virus Type 1 (HIV-1) to Enhance HIV-1 Binding to Cells and Infection
  Virology, 1995
• Effect of Mutations in the V3 Loop of HIV-1 gp120 on Infectivity and Susceptibility to Proteolytic Cleavage
  AIDS Research and Human Retroviruses, 1993
• V3 Loop region of the HIV-1 gpl20 envelope protein is essential for virus infectivity
  Virology, 1992
• Synthetic peptides from the principal neutralizing domain of human immunodeficiency virus type 1 (HIV-1) enhance HIV-1 infection through a CD4-dependent mechanism
  Virology, 1991
• Location and Chemical Synthesis of a Binding Site for HIV-1 on the CD4 Protein
  Science, 1988
• Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120.
  Proceedings of the National Academy of Sciences, 1988
• The CD4 antigen: Physiological ligand and HIV receptor
  Cell, 1988
• Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor
  Cell, 1987